PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Disease and Infection Control Unit, Hillel Yaffe Medical Center, Hadera, Israel.\', \'Rappaport Faculty of Medicine, Technion -Israel Institute of Technology, Haifa, Israel.\', \'Maccabi Healthcare Services, Tel-Aviv, Israel.\', \'Adelson School of Medicine, Ariel University, Ariel, Israel.\', \'Infectious Disease and Infection Control Unit Assuta Medical Center, Ashdod, Israel.\', \'Faculty of Health Sciences, Ben Gurion University in the Negev, Be\'er Sheba, Israel.\', \'Department of Family Medicine, Sharon-Shomron District, Clalit Health Services, Kfar Saba, Israel.\', \'Meuhedet Healthcare Services, Tel-Aviv, Israel.\', \'Leumit Healthcare Services, Tel-Aviv, Israel.\', \'Public Health Services, Israel Ministry of Health, Jerusalem, Israel.\', \'Faculty of Medicine Braun School of Public Health and Community Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/apa.16226
?:doi
?:hasPublicationType
?:journal
  • Acta paediatrica (Oslo, Norway : 1992)
is ?:pmid of
?:pmid
?:pmid
  • 34931371
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • How compassionate use enabled Israel to deliver the Pfizer-BioNTech COVID-19 vaccination to vulnerable children aged 12-15 years before regulatory approval.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34931371>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34931371>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all